Angiotensin II and leukocyte trafficking: New insights for an old vascular mediator. Role of redox-signaling pathways.
Autores de INCLIVA
Grupos y Plataformas de I+D+i
Abstract
Inflammation and activation of the immune system are key molecular and cellular events in the pathogenesis of cardiovascular diseases, including atherosclerosis, hypertension-induced target-organ damage, and abdominal aortic aneurysm. Angiotensin II (Ang-II) is the main effector peptide hormone of the renin-angiotensin system. Beyond its role as a potent vasoconstrictor and regulator of blood pressure and fluid homeostasis, Ang-II is intimately involved in the development of vascular lesions in cardiovascular diseases through the activation of different immune cells. The migration of leukocytes from circulation to the arterial subendothelial space is a crucial immune response in lesion development that is mediated through a sequential and coordinated cascade of leukocyte-endothelial cell adhesive interactions involving an array of cell adhesion molecules present on target leukocytes and endothelial cells and the generation and release of chemoattractants that activate and guide leukocytes to sites of emigration. In this review, we outline the key events of Ang-II participation in the leukocyte recruitment cascade, the underlying mechanisms implicated, and the corresponding redox-signaling pathways. We also address the use of inhibitor drugs targeting the effects of Ang-II in the context of leukocyte infiltration in these cardiovascular pathologies, and examine the clinical data supporting the relevance of blocking Ang-II-induced vascular inflammation. Copyright © 2020 Elsevier Inc. All rights reserved.
© 2020 Elsevier Inc. All rights reserved.
Datos de la publicación
- ISSN/ISSNe:
- 0891-5849, 1873-4596
- Tipo:
- Article
- Páginas:
- 38-54
- PubMed:
- 32057992
FREE RADICAL BIOLOGY AND MEDICINE ELSEVIER SCIENCE INC
Citas Recibidas en Web of Science: 32
Documentos
- No hay documentos
Filiaciones
Keywords
- Angiotensin II; Cell adhesion molecules; Cytokines; Chemokines; Leukocyte; Endothelium; Redox-signaling pathways; Atherosclerosis; Abdominal aortic aneurysm; Hypertension
Financiación
Proyectos y Estudios Clínicos
RETOS 2017. MODULACION FARMACOLOGICA DEL SISTEMA INMUNE COMO DIANA CLAVE EN LA PREVENCION DE LA ENFERMEDAD CARDIOVASCULAR ASOCIADA A DESORDENES METABOLICOS. SINTESIS DE FARMACOS NOVEDOSOS
Investigador Principal: MARIA JESUS SANZ FERRANDO
SAF2017-89714-R . MINISTERIO ECONOMIA Y COMPETITIVIDAD . 2018
Identificación de nuevos mecanismos implicados en la angiogénesis e inflamación en pacientes obesos. Modulación por ligandos de receptores nucleares constitutivos de androstano.
Investigador Principal: JOSE TOMAS REAL COLLADO
PI18/00209 . INSTITUTO SALUD CARLOS III . 2019
Efecto de la cirugía bariátrica en la inflamación vascular en pacientes con obesidad morbida y diabéticos.
Investigador Principal: LAURA PIQUERAS RUIZ
AICO/2019/250 . CONSELLERIA EDUCACION/INNOVACION,UNIVERSIDADES, CIENCIA Y SOCIEDAD DIGITAL/EMPLEO . 2019
CDEI-04/20-A GENT LAURA PIQUERAS (2019/200) CONTRATO
Investigador Principal: LAURA PIQUERAS RUIZ
2019/200C . CONSELLERIA DE SANIDAD
Cita
Piqueras L,Sanz M. Angiotensin II and leukocyte trafficking: New insights for an old vascular mediator. Role of redox-signaling pathways. Free Radic. Biol. Med. 2020. 157. p. 38-54. IF:7,376. (1).
Angiotensin II and leukocyte trafficking: New insights for an old vascular mediator. Role of redox-signaling pathways. Piqueras L, Sanz M. FREE RADICAL BIOLOGY AND MEDICINE. 2020 enero 01. 15738-54. DOI:10.1016/j.freeradbiomed.2020.02.002. PMID:32057992.